Back to Search
Start Over
An engineered β-galactosidase with improved stability and cross-correction for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
- Source :
- Molecular Genetics and Metabolism. 138:107285
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
Details
- ISSN :
- 10967192
- Volume :
- 138
- Database :
- OpenAIRE
- Journal :
- Molecular Genetics and Metabolism
- Accession number :
- edsair.doi...........f1c904fd0acaab184cf602a224ece715